Omeros (OMER) Non-cash Items (2012 - 2026)
Omeros' (OMER) quarterly Non-cash Items came in at $76.0 million in Q1 2026, up 540.57% year-on-year from $11.9 million in Q1 2025, and up 499.48% quarter-over-quarter from $12.7 million in Q4 2025.
Omeros (OMER) Non-cash Items (2012 - 2026) Analysis & Trends
Omeros has disclosed Non-cash Items across 10 years of filings, most recently posting $76.0 million for Q1 2026.
- Non-cash Items for Q1 2026 came in at $76.0 million, up 540.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $76.0 million (up 540.57% YoY), and the FY2025 annual result was $12.7 million, down 77.24% from the prior year.
- Non-cash Items came in at $76.0 million for Q1 2026 at Omeros, up from $12.7 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $76.0 million in Q1 2026 to a low of $15000.0 in Q1 2022.
- The 5-year median for Non-cash Items is $6.9 million (2024), against an average of $12.9 million.
- Across the five-year window, Non-cash Items slumped 99.86% in 2022 and soared 67513.42% in 2023, its largest moves.
- Omeros' Non-cash Items stood at $21000.0 in 2022, then soared by 6509.52% to $1.4 million in 2023, then soared by 3915.71% to $55.7 million in 2024, then slumped by 77.24% to $12.7 million in 2025, then surged by 499.48% to $76.0 million in 2026.
- The last three Non-cash Items figures came in at $76.0 million (Q1 2026), $12.7 million (Q4 2025), and $9.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Omeros | 628.56 Mn | 493.24 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.05 Mn |
| Mar 31, 2026 | 76.05 Mn |
| Dec 31, 2025 | 12.69 Mn |
| Dec 31, 2025 | 12.69 Mn |
| Sep 30, 2025 | 9.81 Mn |
| Sep 30, 2025 | 9.81 Mn |
| Jun 30, 2025 | 12.47 Mn |
| Jun 30, 2025 | 12.47 Mn |
| Mar 31, 2025 | 11.87 Mn |
| Mar 31, 2025 | 11.87 Mn |
| Dec 31, 2024 | 55.74 Mn |
| Dec 31, 2024 | 55.74 Mn |
| Sep 30, 2024 | 6.17 Mn |
| Sep 30, 2024 | 6.17 Mn |
| Jun 30, 2024 | 6.86 Mn |
| Jun 30, 2024 | 6.86 Mn |
| Mar 31, 2024 | 1.89 Mn |
| Mar 31, 2024 | 1.89 Mn |
| Dec 31, 2023 | 1.39 Mn |
| Dec 31, 2023 | 1.39 Mn |